MANGOCEUTICALS INC. -
0.2048
08-October-24 11:30:28
15 minutes delayed
Stocks
-0.0129
-5.93%
Today's range
0.1955 - 0.2177
ISIN
N/A
Source
NASDAQ
-
MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
03 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
01 Oct 2024 06:30:00 By Nasdaq GlobeNewswire
-
15 Aug 2024 08:25:00 By Nasdaq GlobeNewswire
-
13 Aug 2024 15:00:00 By Nasdaq GlobeNewswire
-
09 Aug 2024 07:15:00 By Nasdaq GlobeNewswire
-
MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology
24 Jul 2024 07:15:00 By Nasdaq GlobeNewswire
-
Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access
18 Jul 2024 15:05:00 By Nasdaq GlobeNewswire
-
MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts
16 Jul 2024 07:20:00 By Nasdaq GlobeNewswire
-
12 Jul 2024 12:30:00 By Nasdaq GlobeNewswire
-
MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets
11 Jul 2024 07:15:00 By Nasdaq GlobeNewswire
-
06 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
-
04 Jun 2024 15:00:00 By Nasdaq GlobeNewswire
-
04 Jun 2024 07:00:01 By Nasdaq GlobeNewswire
-
28 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
23 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
21 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
16 May 2024 15:40:00 By Nasdaq GlobeNewswire
-
02 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care
25 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >